Novel therapeutic targets of epilepsy include interleukin (IL)-1β, cyclooxygenase (COX), tumor necrosis factor (TNF), and IL-6 receptor (DeSena et al., 2018; Lagarde et al., 2016; Lance et al., 2013). The gene discussed is IL1B; the disease is epilepsy.